Bioquell has launched a new fully-integrated hydrogen peroxide vapour (HPV) workstation for rapid sporicidal bio-decontamination.
The Bioquell QUBE, launched this week, and offers a high-level validated six-log reduction in bioburden and has been specially designed to complement a fully-fitted and validated sterility test unit such as the Millipore Steritest system.
Developed as a modular, barrier separation system, the Bioquell QUBE provides a physical separation of operators to the sterility test process. The closed barrier technology enables the user to apply the automated HPV biological decontamination. Within a single module, a rapid 20-minute bio-decontamination cycle allows fast and efficient transfers. An EU GMP Grade A/ISO 5 compliant environment is ensured by both uni-directional airflow and unique isolator technology.
The intelligent modular design gives users flexibility in selecting the most suitable configuration for their individual processes. If space is limited, a single module can be installed while, where there is a need for high volume throughput, a three chamber workstation can be implemented.
Commenting on the launch, Dr Tim Flanagan, head of life sciences at Bioquell, said: “Modern technology has to meet the challenges of modern processing and our new Bioquell QUBE has been designed to do just that. It enables you to expand with your process by simply adding modules while its rapid bio-decontamination cycle gives fast batch turnaround. And all of this is backed by Bioquell’s unmatched experience in bio-decontamination technology, developed over the last 200 years.”